IP Library › Granted Patent US 9,750,846
Granted Patent B2
US 9,750,846 · App. 13/458,573 · Granted Sep 5, 2017

Bioresorbable and biocompatible compounds for surgical use

Inventors: Philippe Gravagna (Irigny, FR); Yves Bayon (Lyons, FR); Sebastien Ladet (Lyons, FR)
Assignee: Sofradim Production SAS
A61L27/20A61L27/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,750,846
App. No.
13/458,573
Granted
Sep 5, 2017
Kind
B2
Abstract

A bioresorbable and biocompatible compound for surgical use is composed of functionalized collagen cross-linked with a glycosaminoglycan.

Claims (16)

1. A compound comprising a functionalized collagen covalently bonded directly to chitosan without the use of a crosslinking agent, wherein the chitosan has a degree of acetylation from about 35 to 50% and wherein the collagen is functionalized by oxidative cleavage.

2. A compound as in claim 1 wherein the functionalized collagen includes one or more reactive moieties selected from the group consisting of aldehydes, sulfones, vinylsulfones, isocyanates, and acid anhydrides.

3. The compound of claim 1 wherein the functionalized collagen includes one or more reactive moieties selected from the group consisting of —CO 2 N(COCH 2 ) 2 , —CO 2 N(COCH 2 ) 2 , —CO 2 H, —CHO, —CHOCH 2 , —N═C═O, —SO 2 CH═CH 2 , —N(COCH) 2 , and —S—S—(C 5 H 4 N).

4. The compound of claim 1 wherein the functionalized collagen is covalently bonded to at least a second chitosan with a degree of acetylation selected from about 0.5 to 60%.

5. An implant comprising a compound containing a functionalized collagen covalently bonded directly to chitosan without the use of a crosslinking agent, wherein the chitosan has a degree of acetylation from about 35 to 50% and wherein the collagen is functionalized by oxidative cleavage.

6. The implant of claim 5 comprising a sponge containing said compound.

7. The implant of claim 5 comprising a textile containing said compound.

8. The implant of claim 5 comprising a hydrogel containing said compound.

9. The implant of claim 5 comprising threads containing said compound.

10. The implant of claim 5 comprising a non knitted, non woven composite containing said compound.

11. The implant of claim 5 comprising a film containing said compound.

12. The implant of claim 5 comprising a mesh coated with a composition containing said compound.

13. A method of forming a bioresorbable compound comprising contacting a functionalized collagen with a glycosaminoglycan without the use of a crosslinking agent, wherein the glycosaminoglycan is chitosan having a degree of acetylation from about 35% to 50% and wherein the collagen is functionalized by oxidative cleavage, wherein a deionized water solution of functionalized collagen is combined to a deionized water solution of chitosan having a degree of acetylation from about 35% to 50% to allow the functionalized collagen to mix with the chitosan and form said compound.

14. The method of claim 13 , wherein the pH of the solution of functionalized collagen is adjusted between 2 and 7.5.

15. The method of claim 13 , wherein the pH of the solution of glycosaminoglycan is adjusted between 2 and 7.5.

16. The method of claim 14 , wherein the pH of the solution of glycosaminoglycan is adjusted between 2 and 7.5.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2017
From: GRAVAGNA, PHILIPPE; BAYON, YVES; LADET, SEBASTIEN
To: SOFRADIM PRODUCTION
Reel/Frame 041053/0196 →
Continuity (2)
Continuation 11899694 · Sep 7, 2007
Related Publication 20120276161A1 · Nov 1, 2012